Key points are not available for this paper at this time.
In this cohort study of patients with advanced solid tumors treated with ICIs in diverse clinics, TMB-H cancers were significantly associated with improved clinical outcomes compared with TMB-L cancers.
Aggarwal et al. (2023) studied this question.